Concepedia

Viswanathan Ramasamy

VR

Statistics

Publications

6

Citations

226

H-Index

6

Active since

2006

Affiliations

International Centre for Genetic Engineering and Biotechnology(Current)

Translational Health Science and Technology Institute

Icahn School of Medicine at Mount Sinai

Viswanathan Ramasamy is an author at International Centre for Genetic Engineering and Biotechnology specializing in infectious diseases, viral vaccines, and immunology.

ORCID

Publications per year

2006–2020

6

Publications

6

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice

Viswanathan Ramasamy, Upasana Arora, Rahul Shukla et al. · PLoS neglected tropical diseases · 2018 · 96 citations · Full text

, , +17

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models

Rahul Shukla, Hemalatha Beesetti, Julia A. Brown et al. · EBioMedicine · 2020 · 40 citations · Full text

, , +17

Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies

Ankur Poddar, Viswanathan Ramasamy, Rahul Shukla et al. · BMC Biotechnology · 2016 · 29 citations · Full text

, , +16

Development of monoclonal antibodies against VP28 of WSSV and its application to detect WSSV using immunocomb

M. Makesh, A. Koteeswaran, N. Daniel Joy Chandran et al. · Aquaculture · 2006 · 23 citations

, , +12

<i>Pichia pastoris</i>-expressed Zika virus envelope domain III on a virus-like particle platform: design, production and immunological evaluation

Rajgokul K. Shanmugam, Viswanathan Ramasamy, Rahul Shukla et al. · Pathogens and Disease · 2019 · 21 citations · Full text

, , +17

1–5 of 6